Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCε/PKCε Signaling Pathway.

Frontiers in Oncology
Jiayu LiuXiaohou Wu

Abstract

Castration-resistant prostate cancer (CRPC) is a progressed stage of prostate cancer, which requires better understanding of the mechanisms and remains an unmet clinical need. As a common oncogene, K-Ras is associated with malignant behavior in different types of tumors but its role in CRPC is unknown. The present study aims to find the mechanism of K-Ras in CRPC and whether it can be used as a crucial molecule for the treatment of CRPC. For this purpose, tissue samples from primary prostate cancer (PPC) and CRPC patients were analyzed by immunohistochemistry and the data showed that K-Ras was elevated in CRPC. More importantly, higher K-Ras expression was related to a shorter recurrence-free survival time in patients with CRPC. In addition, K-Ras promoted the invasion, migration, and drug resistance of CRPC cells by activation of PLCε/PKCε signaling pathway. Meanwhile, the inhibitor of K-RasG12C mutants was able to inhibit malignant behavior of CRPC cells in vitro and in vivo. Inhibitors of K-RasG12C mutants have entered clinical trials. Taken together, the study shows that K-Ras may activate PKCε through PLCε, resulting in the alterations of malignant behavior of CRPC. Inhibitor 9, an inhibitor of the K-RasG12C mutant, has a ...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jan 2, 2003·Nature Reviews. Cancer·Julian Downward
Feb 4, 2005·The New England Journal of Medicine·Jeffrey A Meyerhardt, Robert J Mayer
Sep 15, 2007·Nature Protocols·Daniel Lingwood, Kai Simons
Aug 8, 2009·The Journal of Biological Chemistry·Kerry L InderJohn F Hancock
Jan 13, 2011·Cell Cycle·Fernando BenavidesMarcelo G Kazanietz
Oct 14, 2011·Nature Reviews. Cancer·Yuliya Pylayeva-GuptaDafna Bar-Sagi
Jan 31, 2012·Cellular Signalling·Alan V SmrckaGeorge G Holz
Aug 9, 2012·The Journal of Endocrinology·Kelly Coffey, Craig N Robson
Aug 17, 2012·The New England Journal of Medicine·Howard I ScherUNKNOWN AFFIRM Investigators
Nov 7, 2012·Molecular and Cellular Biology·Dharini van der HoevenJohn F Hancock
Nov 10, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R J van SoestW M van Weerden
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 29, 2014·Lancet· The Lancet
May 17, 2014·Asian Journal of Andrology·Min QuYing-Hao Sun
Aug 2, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Ling-Bin DuWei-Min Mao
Sep 4, 2014·The New England Journal of Medicine·Emmanuel S AntonarakisJun Luo
Oct 18, 2014·Nature Reviews. Drug Discovery·Adrienne D CoxChanning J Der
Oct 30, 2014·The New England Journal of Medicine·Tomasz M Beer, Bertrand Tombal
Oct 30, 2014·The New England Journal of Medicine·Michael Froehner, Manfred P Wirth
Dec 2, 2014·Nature Reviews. Drug Discovery·Ahmed A Samatar, Poulikos I Poulikakos
Mar 12, 2015·Cancer Cell·Frederick H WilsonLevi A Garraway
Apr 17, 2015·Nature·Heidi Ledford
Jun 26, 2015·Journal of Cancer Research and Clinical Oncology·Rui-Yan ZhangDong-Sheng Pei
Aug 19, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R J van SoestUNKNOWN Dutch Uro-Oncology Studygroup (DUOS)
Sep 4, 2015·Clinical Pharmacology and Therapeutics·Daniel J CronaYoung E Whang
Nov 14, 2015·Nature Reviews. Cancer·Philip A WatsonCharles L Sawyers
Jul 17, 2016·Seminars in Cell & Developmental Biology·Bingying ZhouAdrienne D Cox
Jun 6, 2017·The New England Journal of Medicine·Nicholas D JamesUNKNOWN STAMPEDE Investigators
Jan 28, 2019·International Journal of Biological Macromolecules·Xiyan ZhangLiming Dong
Aug 7, 2019·Journal of Experimental & Clinical Cancer Research : CR·Jiaxin FanChunli Luo
Aug 24, 2019·Molecular Cancer Therapeutics·Huai-Xiang HaoMorvarid Mohseni

❮ Previous
Next ❯

Methods Mentioned

BETA
protein assay
electrophoresis
xenograft
Co-IP
xenografts
X-ray

Software Mentioned

IMAGE J
Pro Plus
GraphPad Prism
SPSS
Image

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Related Papers

Ugeskrift for laeger
Sissal Sigmundsdòttir DjurhuusMartin Andreas Røder
Nihon rinsho. Japanese journal of clinical medicine
Seiichiro Ozono, Hiroshi Furuse
Nihon rinsho. Japanese journal of clinical medicine
Seiichiro Ozono, Hiroshi Furuse
© 2021 Meta ULC. All rights reserved